CLASS II Drug recall · Reported 5 Feb 2020 · FDA Enforcement Report

Dimercaptopropanesulfonate Sodium (DMPS) recalled

McGuff Compounding Pharmacy Services is recalling Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL SDV, distributed in 19 states. The recall was initiated on 14 Feb 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #18J1081, Exp 03/10/19

Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-0821-2020
FDA event ID: 84622
Recalling firm: McGuff Compounding Pharmacy Services, Santa Ana, CA
Classification: Class II
Status: Terminated
Recall initiated: 14 Feb 2019
FDA classified: 29 Jan 2020
Reported: 5 Feb 2020
Type: Voluntary: Firm initiated
Customers notified by: Telephone
Reason category: Particulate Matter
Drug class: Injectable & IV Drugs

Timeline

14 Feb 2019	Recall initiated by company
29 Jan 2020	Classified by FDA	+349 days
5 Feb 2020	Published in enforcement report	+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: Particulates observed in vials release for dispensing.

Product as listed by the FDA

Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704

Where it was distributed

Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.

Alaska Arizona California Colorado District of Columbia Florida Indiana Massachusetts Montana North Carolina New Jersey New York Oregon South Carolina Texas Utah Virginia Washington Wisconsin

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: Particulates observed in vials release for dispensing.

Which lots are affected?

Lot #18J1081, Exp 03/10/19

Where was it sold?

Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from McGuff Compounding Pharmacy Services

All 4

Reported	Class	Recall	Company	Reason	Where
22 Feb 2023Drug	CLASS II	Thiamine Hydrochloride 3000 mg/ (100mg/mL) recalled	McGuff Compounding Pharmacy Services	Particulate Matter	Nationwide
22 Feb 2023Drug	CLASS II	Thiamine Hydrochloride 200 mg/ (100mg/mL), Riboflavin 2 mg recalled	McGuff Compounding Pharmacy Services	Particulate Matter	Nationwide
22 Jan 2020Drug	CLASS II	Lipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic recalled	McGuff Compounding Pharmacy Services	Particulate Matter	Nationwide